1-9 of 9
Axel Walch
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Spatial Metabolomics Identifies Distinct Tumor-Specific Subtypes in Gastric Cancer Patients

Jun Wang, Thomas Kunzke, Verena M. Prade, Jian Shen, Achim Buck, Annette Feuchtinger, Ivonne Haffner, Birgit Luber, Drolaiz H.W. Liu, Rupert Langer, Florian Lordick, Na Sun, Axel Walch
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (13): 2865–2877.
https://doi.org/10.1158/1078-0432.CCR-21-4383
Published: 01 July 2022
View article titled, Spatial Metabolomics Identifies Distinct Tumor-Specific Subtypes in Gastric Cancer Patients
Open the PDF for Spatial Metabolomics Identifies Distinct Tumor-Specific Subtypes in Gastric Cancer Patients in another window
Includes: Supplementary data
Journal Articles

Therapy-Related Transcriptional Subtypes in Matched Primary and Recurrent Head and Neck Cancer

Peter Weber, Axel Künstner, Julia Hess, Kristian Unger, Sebastian Marschner, Christian Idel, Julika Ribbat-Idel, Philipp Baumeister, Olivier Gires, Christoph Walz, Sibylle Rietzler, Laura Valeanu, Timm Herkommer, Lisa Kreutzer, Olena Klymenko, Guido Drexler, Thomas Kirchner, Cornelius Maihöfer, Ute Ganswindt, Axel Walch, Michael Sterr, Heiko Lickert, Martin Canis, Dirk Rades, Sven Perner, Mauricio Berriel Diaz, Stefan Herzig, Kirsten Lauber, Barbara Wollenberg, Hauke Busch, Claus Belka, Horst Zitzelsberger
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (5): 1038–1052.
https://doi.org/10.1158/1078-0432.CCR-21-2244
Published: 03 March 2022
View article titled, Therapy-Related Transcriptional Subtypes in Matched Primary and Recurrent Head and Neck Cancer
Open the PDF for Therapy-Related Transcriptional Subtypes in Matched Primary and Recurrent Head and Neck Cancer in another window
Includes: Supplementary data
Journal Articles

A Five-MicroRNA Signature Predicts Survival and Disease Control of Patients with Head and Neck Cancer Negative for HPV Infection

Julia Hess, Kristian Unger, Cornelius Maihoefer, Lars Schüttrumpf, Ludmila Wintergerst, Theresa Heider, Peter Weber, Sebastian Marschner, Herbert Braselmann, Daniel Samaga, Sebastian Kuger, Ulrike Pflugradt, Philipp Baumeister, Axel Walch, Christine Woischke, Thomas Kirchner, Martin Werner, Kristin Werner, Michael Baumann, Volker Budach, Stephanie E. Combs, Jürgen Debus, Anca-Ligia Grosu, Mechthild Krause, Annett Linge, Claus Rödel, Martin Stuschke, Daniel Zips, Horst Zitzelsberger, Ute Ganswindt, Michael Henke, Claus Belka
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (5): 1505–1516.
https://doi.org/10.1158/1078-0432.CCR-18-0776
Published: 01 March 2019
View article titled, A Five-MicroRNA Signature Predicts Survival and Disease Control of Patients with Head and Neck Cancer Negative for HPV Infection
Open the PDF for A Five-MicroRNA Signature Predicts Survival and Disease Control of Patients with Head and Neck Cancer Negative for HPV Infection in another window
Includes: Supplementary data
Journal Articles

Model Matters: Differences in Orthotopic Rat Hepatocellular Carcinoma Physiology Determine Therapy Response to Sorafenib

Claudia Groß, Katja Steiger, Sufyan Sayyed, Irina Heid, Annette Feuchtinger, Axel Walch, Julia Heß, Kristian Unger, Horst Zitzelsberger, Marcus Settles, Anna Melissa Schlitter, Juliane Dworniczak, Jennifer Altomonte, Oliver Ebert, Markus Schwaiger, Ernst Rummeny, Andreas Steingötter, Irene Esposito, Rickmer Braren
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (19): 4440–4450.
https://doi.org/10.1158/1078-0432.CCR-14-2018
Published: 30 September 2015
View article titled, Model Matters: Differences in Orthotopic Rat Hepatocellular Carcinoma Physiology Determine Therapy Response to Sorafenib
Open the PDF for Model Matters: Differences in Orthotopic Rat Hepatocellular Carcinoma Physiology Determine Therapy Response to Sorafenib in another window
Includes: Supplementary data
Journal Articles

Molecular Analysis of HER2 Signaling in Human Breast Cancer by Functional Protein Pathway Activation Mapping

Julia D. Wulfkuhle, Daniela Berg, Claudia Wolff, Rupert Langer, Kai Tran, Julie Illi, Virginia Espina, Mariaelena Pierobon, Jianghong Deng, Angela DeMichele, Axel Walch, Holger Bronger, Ingrid Becker, Christine Waldhör, Heinz Höfler, Laura Esserman, on behalf of the I-SPY 1 TRIAL Investigators, Lance A. Liotta, Karl-Friedrich Becker, Emanuel F. Petricoin, III
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (23): 6426–6435.
https://doi.org/10.1158/1078-0432.CCR-12-0452
Published: 29 November 2012
View article titled, Molecular Analysis of HER2 Signaling in Human Breast Cancer by Functional Protein Pathway Activation Mapping
Open the PDF for Molecular Analysis of HER2 Signaling in Human Breast Cancer by Functional Protein Pathway Activation Mapping in another window
Includes: Supplementary data
Journal Articles

Genomic Alterations and Allelic Imbalances Are Strong Prognostic Predictors in Osteosarcoma

Jan Smida, Daniel Baumhoer, Michael Rosemann, Axel Walch, Stefan Bielack, Christopher Poremba, Klaus Remberger, Eberhard Korsching, Wolfram Scheurlen, Christian Dierkes, Stefan Burdach, Gernot Jundt, Michael J. Atkinson, Michaela Nathrath
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (16): 4256–4267.
https://doi.org/10.1158/1078-0432.CCR-10-0284
Published: 11 August 2010
View article titled, Genomic Alterations and Allelic Imbalances Are Strong Prognostic Predictors in Osteosarcoma
Open the PDF for Genomic Alterations and Allelic Imbalances Are Strong Prognostic Predictors in Osteosarcoma in another window
Journal Articles

Significance of HER2 Low-Level Copy Gain in Barrett's Cancer: Implications for Fluorescence In situ Hybridization Testing in Tissues

Sandra Rauser, Roland Weis, Herbert Braselmann, Marcus Feith, Hubert J. Stein, Rupert Langer, Peter Hutzler, Michael Hausmann, Silke Lassmann, Jörg Rüdiger Siewert, Heinz Höfler, Martin Werner, Axel Walch
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (17): 5115–5123.
https://doi.org/10.1158/1078-0432.CCR-07-0465
Published: 04 September 2007
View article titled, Significance of HER2 Low-Level Copy Gain in Barrett's Cancer: Implications for Fluorescence <em>In situ</em> Hybridization Testing in Tissues
Open the PDF for Significance of HER2 Low-Level Copy Gain in Barrett's Cancer: Implications for Fluorescence <em>In situ</em> Hybridization Testing in Tissues in another window
Journal Articles

Predictive Value of Aurora-A/STK15 Expression for Late Stage Epithelial Ovarian Cancer Patients Treated by Adjuvant Chemotherapy

Silke Lassmann, Yi Shen, Uta Jütting, Philipp Wiehle, Axel Walch, Gerald Gitsch, Annette Hasenburg, Martin Werner
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (14): 4083–4091.
https://doi.org/10.1158/1078-0432.CCR-06-2775
Published: 18 July 2007
View article titled, Predictive Value of Aurora-A/STK15 Expression for Late Stage Epithelial Ovarian Cancer Patients Treated by Adjuvant Chemotherapy
Open the PDF for Predictive Value of Aurora-A/STK15 Expression for Late Stage Epithelial Ovarian Cancer Patients Treated by Adjuvant Chemotherapy in another window
Journal Articles

Aurora Kinase A Messenger RNA Overexpression Is Correlated with Tumor Progression and Shortened Survival in Head and Neck Squamous Cell Carcinoma

Rudolf Reiter, Peter Gais, Uta Jütting, Miriam K. Steuer-Vogt, Anja Pickhard, Karin Bink, Sandra Rauser, Silke Lassmann, Heinz Höfler, Martin Werner, Axel Walch
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (17): 5136–5141.
https://doi.org/10.1158/1078-0432.CCR-05-1650
Published: 01 September 2006
View article titled, Aurora Kinase A Messenger RNA Overexpression Is Correlated with Tumor Progression and Shortened Survival in Head and Neck Squamous Cell Carcinoma
Open the PDF for Aurora Kinase A Messenger RNA Overexpression Is Correlated with Tumor Progression and Shortened Survival in Head and Neck Squamous Cell Carcinoma in another window